Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 06, 2023

SELL
$9.59 - $11.35 $5,044 - $5,970
-526 Reduced 2.15%
23,987 $236,000
Q2 2023

Aug 01, 2023

SELL
$9.02 - $10.29 $32,111 - $36,632
-3,560 Reduced 12.68%
24,513 $244,000
Q1 2023

May 05, 2023

BUY
$9.2 - $12.26 $14,738 - $19,640
1,602 Added 6.05%
28,073 $270,000
Q4 2022

Jan 24, 2023

SELL
$8.72 - $11.56 $2,110 - $2,797
-242 Reduced 0.91%
26,471 $0
Q3 2022

Nov 10, 2022

BUY
$8.48 - $11.13 $1,492 - $1,958
176 Added 0.66%
26,713 $228,000
Q2 2022

Aug 11, 2022

SELL
$9.95 - $12.27 $259,147 - $319,572
-26,045 Reduced 49.53%
26,537 $278,000
Q1 2022

Apr 20, 2022

BUY
$9.81 - $15.4 $230,113 - $361,237
23,457 Added 80.54%
52,582 $572,000
Q4 2021

Feb 02, 2022

BUY
$12.09 - $14.68 $231,039 - $280,534
19,110 Added 190.81%
29,125 $394,000
Q3 2021

Oct 28, 2021

SELL
$13.25 - $15.13 $8,466 - $9,668
-639 Reduced 6.0%
10,015 $136,000
Q2 2021

Aug 13, 2021

SELL
$12.97 - $16.15 $39,584 - $49,289
-3,052 Reduced 22.27%
10,654 $152,000
Q1 2021

May 06, 2021

SELL
$13.59 - $18.54 $149,354 - $203,754
-10,990 Reduced 44.5%
13,706 $191,000
Q4 2020

Feb 09, 2021

BUY
$14.3 - $18.74 $353,152 - $462,803
24,696 New
24,696 $463,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Sigma Planning Corp Portfolio

Follow Sigma Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.